Competency information

Details

Select the correct genetic tests for patients referred with a suspected neuromuscular disorder.

Considerations

  • The range of tests suitable for patients presenting with particular neuromuscular symptoms.
  • The genetic alterations and genes responsible for a range of neuromuscular disorders, e.g. B/DMD, DM and SMA.
  • The range of genetic testing relevant to diagnostic and carrier/predictive testing for neuromuscular disorders.
  • The distinction between in-frame and out of frame dystrophin mutations and the ability to interpret B/DMD testing results appropriately.
  • The use of linkage analysis (B/DMD and SMA) and the ability to evaluate the risks of recombination.

Relevant learning outcomes

# Outcome
# 1 Outcome Apply an appropriate testing strategy relevant to patients referred for paediatric disorders.
# 3 Outcome Perform targeted testing for patients referred with paediatric genetic conditions.
# 4 Outcome Investigate the clinical significance of variants using a range of bioinformatics tools, following current best practice guidelines.
# 5 Outcome Interpret and report a range of genetic and genomic testing relevant to paediatric conditions, including the results of diagnostic testing which should encompass appropriate recommendations for patient management.